These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3671011)

  • 41. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
    Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
    Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current approaches to the treatment of diffuse toxic goiter].
    Balabolkin MI
    Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of pregnant patients with Basedow's disease.
    Momotani N; Ito K
    Exp Clin Endocrinol; 1991 May; 97(2-3):268-74. PubMed ID: 1680727
    [No Abstract]   [Full Text] [Related]  

  • 45. Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy.
    Kruljac I; Solter D; Vrkljan AM; Solter M
    Endocr Res; 2015; 40(1):25-8. PubMed ID: 24833206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
    Aliakparova ASh
    Sov Med; 1973 Dec; 36(12):45-8. PubMed ID: 4130665
    [No Abstract]   [Full Text] [Related]  

  • 47. [Quality of life of patients before and after surgical treatment of diffuse toxic goiter].
    Il'icheva EA; Zudaev VP; Roĭ TA; Makhutov VN; Tarnueva IF; Moshkova ES
    Vestn Khir Im I I Grek; 2011; 170(4):58-63. PubMed ID: 22191260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxic diffuse goiter in children.
    Mosier HD
    GP; 1969 Aug; 40(2):110-6. PubMed ID: 5819609
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative curative effect of Mercasolyl and potassium perchlorate in treating patients with diffuse toxic goiter].
    Anvarova ShS
    Sov Med; 1972 Jul; 35(7):84-8. PubMed ID: 4115205
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyroid failure after potassium iodide treatment of diffuse toxic goiter.
    Wood LC; Maloof F
    Trans Assoc Am Physicians; 1975; 88():235-47. PubMed ID: 1243786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of hyperthyroidisms in Brazzaville Teaching Hospital, Congo].
    Monabeka HG; Bouenizabila E; Ondzotto G
    Bull Soc Pathol Exot; 2005 Jun; 98(2):91-3. PubMed ID: 16050372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.
    Vitti P; Rago T; Chiovato L; Pallini S; Santini F; Fiore E; Rocchi R; Martino E; Pinchera A
    Thyroid; 1997 Jun; 7(3):369-75. PubMed ID: 9226205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease.
    Bouma DJ; Kammer H; Greer MA
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1138-42. PubMed ID: 6182155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diffuse toxic goiter in children].
    Sapelkina LV; Skripkina VM; Demidova LV; Zamoskovnaia VA; Luk'ianova TA
    Vopr Okhr Materin Det; 1978 Jul; 23(7):24-8. PubMed ID: 581106
    [No Abstract]   [Full Text] [Related]  

  • 57. [Diffuse toxic goiter in children].
    Sapelkina LV; Martynova MI; Dapchenko LN; Iankovskaia VN; Skripkina VM
    Pediatriia; 1976 Sep; (9):10-5. PubMed ID: 1037023
    [No Abstract]   [Full Text] [Related]  

  • 58. [Functional state of the cardiovascular system in primary toxic, diffuse goiter].
    Neĭmark MI
    Kardiologiia; 1979 Mar; 19(3):92-3. PubMed ID: 581888
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of the therapy of thyrotoxicosis on the status of the reproductive system of girls with diffuse toxic goiter].
    Varlamova TM; Kerova AN
    Pediatriia; 1987; (7):69-71. PubMed ID: 3671011
    [No Abstract]   [Full Text] [Related]  

  • 60. [Function of the reproductive system in pre- and pubescent girls with diffuse toxic goiter and hypothyroidism].
    Varlamova TM; Shchedrina RN; Mataradze GD
    Probl Endokrinol (Mosk); 1988; 34(4):36-40. PubMed ID: 3194356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.